All Stories

  1. Diet and sex inequities in ischemic heart disease mortality across Europe: findings from the global burden of disease study
  2. Changing clinical perspectives on sex and healthcare disparities in ischaemic heart disease
  3. Age and sex differences in the efficacy of early invasive strategy for non-ST-elevation acute coronary syndrome: A comparative analysis in stable patients
  4. AGE AND SEX DIFFERENCES IN THE EFFICACY OF EARLY INVASIVE STRATEGY FOR NON-STELEVATION ACUTE CORONARY SYNDROME: A COMPARATIVE ANALYSIS IN STABLE PATIENTS
  5. 225 Basic/Advanced Life Support Training for Healthcare Professionals in the European Union
  6. Biochemical variables as predictors of in-hospital mortality in patients with acute coronary syndrome
  7. Early coronary revascularization among stable patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age
  8. Unraveling the paradox: the impact of one or more traditional risk factors on short-term mortality following acute coronary syndromes.
  9. Early coronary revascularization among ‘stable’ patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age
  10. Editorial: Insights in intensive care cardiovascular medicine: 2022
  11. The European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation
  12. Coronary revascularization and sex differences in cardiovascular mortality after myocardial infarction in 12 high and middle-income European countries
  13. TRADITIONAL RISK FACTORS AND PREMATURE ACUTE CORONARY SYNDROMES IN SOUTH EASTERN EUROPE
  14. Acute kidney injury in patients with acute coronary syndrome - risk profile
  15. Left ventricular systolic function in patients with acute coronary syndrome-risk profile
  16. The role of pre-existing renal dysfunction on in-hospital morbidity and mortality in patients with acute coronary syndrome
  17. Traditional risk factors and premature acute coronary syndromes in South Eastern Europe: a multinational cohort study
  18. Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
  19. Abstract 18529: Early Coronary Revascularization Among "Stable" Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: The Role of Diabetes and Age
  20. Abstract 16665: Traditional Risk Factors and Acute Coronary Syndrome Free Survival
  21. Ischemic burden and cardiovascular mortality in 12 middle- and high-income European countries
  22. Age and Gender Impact on Heart Rate Variability towards Noninvasive Glucose Measurement
  23. Rosuvastatin effects on the HDL proteome in hyperlipidemic patients
  24. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers
  25. Correction to: Relationship between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
  26. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
  27. Sex Differences in Heart Failure Following Acute Coronary Syndromes
  28. SEX DIFFERENCES AND DISPARITIES IN CARDIOVASCULAR COMPLICATIONS AND INTENSIVE CARE UNIT ADMISSION ASSOCIATED WITH COVID-19
  29. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
  30. Sex differences and disparities in cardiovascular outcomes of COVID-19
  31. Evaluation of ongoing stability data for Zolpidem film coated tablets using statistical methods for trending analysis
  32. Abstract 11122: Sex Differences and Disparities in Cardiovascular Outcomes of Covid-19
  33. Cohort Profile: The ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
  34. COVID-19 and acute heart failure among patients with cancer
  35. Prevalence of standard modifiable cardiovascular risk factors in patients with ST segment elevation myocardial infarction and its relation with outcomes
  36. Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure
  37. Relation between sex and mortality after myocardial infarction in high-income and middle-income European countries
  38. Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development
  39. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19
  40. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation
  41. Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects
  42. SEX DIFFERENCES IN MORTALITY AFTER MYOCARDIAL INFARCTION IN HIGH-INCOME AND MIDDLE-INCOME EUROPEAN COUNTRIES.
  43. Incremental Value of Cardiac Biomarkers in Mid-term Prognosis of Patients with Acute Coronary Syndrome
  44. Comparing Time and Frequency Domain Heart Rate Variability for Deep Learning-Based Glucose Detection
  45. THE EFFECT OF METHYLPREDNISOLONE VERSUS DEXAMETHASONE IN INCREASING THE DIABETOGENIC EFFECT OF SARS-CoV-2 INFECTION AND THE DEVELOPMENT OF A NEW-ONSET DIABETES MELLITUS
  46. Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk
  47. Left Ventricular Aneurysm with Recurrent Ventricular Tachycardia
  48. Abstract 13310: Early Percutaneous Coronary Intervention: Risks and Outcomes in Patients With Cancer
  49. Acute heart failure: a mechanism underscoring sex differences in outcomes following acute coronary syndromes
  50. Is early percutaneous coronary intervention safe in patients ACS and cancer?
  51. Distribution Analysis of Long-Term Heart Rate Variability Versus Blood Glucose
  52. Developing A Deep Learning Solution to Estimate Instantaneous Glucose Level from Heart Rate Variability
  53. Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
  54. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the Eu...
  55. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World
  56. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia
  57. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry
  58. Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation positio...
  59. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe
  60. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19
  61. SEX DIFFERENCES IN HEART FAILURE FOLLOWING ACUTE CORONARY SYNDROMES
  62. STATINS AND SEVERITY OF CLINICAL MANIFESTATIONS AMONG WOMEN AND MEN WITH INCIDENT CORONARY HEART DISEASE
  63. Comparison of 24 h ECG Holter Monitoring with Real-time Long-term ECG Monitoring System using ECGalert Software and Savvy Single-Lead Patch
  64. International Impact of COVID-19 on the Diagnosis of Heart Disease
  65. GENDER DIFFERENCES AND PREDICTORS OF INCRASED CORONARY CALCIUM SCORE AND MYOCARDIAL ISCHEMIA IN DIABETES TYPE 2 PATIENTS
  66. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry
  67. Correlating Short-Term Heart Rate Variability and Instantaneous Blood Glucose Measurements
  68. Heart Rate Variability of 30-minute ECG Measurements and Correlation to Glucose Levels
  69. Abstract 13648: Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease
  70. Added Value of Modified Anderson–Wilkins Acuteness Score in Prognostication of Patients with Acute Myocardial Infarction
  71. Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification
  72. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI
  73. Risk factors, revascularization therapies and cardiovascular mortality in countries with middle and low public health expenditure
  74. Is there a place for rosuvastatin in the Lp(a) management?
  75. Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease
  76. Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors
  77. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’
  78. Organization of intensive cardiac care units in Europe: Results of a multinational survey
  79. Correlating Glucose Regulation with Lipid Profile
  80. Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction
  81. P6419Machine learning in critical care: the role of diabetes and age in acute coronary syndromes
  82. P3844Percutaneous coronary intervention in the age of frailty
  83. 2018 ESC Guidelines for the diagnosis and management of syncope
  84. 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension
  85. “DE NOVO” HEART FAILURE: A MECHANISM UNDERSCORING SEX DIFFERENCES IN OUTCOMES AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
  86. 2018 ESC/ESH Guidelines for the management of arterial hypertension
  87. Sex‐Specific Treatment Effects After Primary Percutaneous Intervention: A Study on Coronary Blood Flow and Delay to Hospital Presentation
  88. 2018 ESC/ESH Guidelines for the management of arterial hypertension
  89. When statin alone or in combination with ezetimibe are not еnough.
  90. Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy – Prevalence and Correlation with Proatherogenic Factors
  91. 2018 ESC/ESH Guidelines for the management of arterial hypertension
  92. 2018 ESC Guidelines for the diagnosis and management of syncope
  93. P580Sex difference in the impact of delay to reperfusion on coronary blood flow and outcomes in ST-segment elevation myocardial infarction
  94. Adding ezetimibe to statin therapy: latest evidence and clinical implications
  95. The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome
  96. Perfusión tejido-músculo evaluada mediante protocolo de un día de gammagrafía reposo-dipiramidol con 99m Tc-MIBI en pacientes no diabéticos y diabéticos
  97. Tissue-muscle perfusion assessed by one day 99m Tc-MIBI rest-dipyridamol scintigraphy in non-diabetic and diabetic patients
  98. Effects of treatment with Statine on Dislipidemia in patients with diabetes.
  99. 2018 ESC Guidelines for the diagnosis and management of syncope
  100. IMPACT OF THE AGE OF FRAILTY ON OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES
  101. Secondary Thromboprophylaxis in Hereditary Thrombophilia
  102. Machine Learning in Critical Care: The Role of Diabetes and Age in Acute Coronary Syndromes
  103. Acute Coronary Syndrome: The Risk to Young Women
  104. P4652Myocardial infarction: process of care measures in eastern Europe: insights for complementary metrics
  105. Influence of ABCB1 C3435T Genotype on Clinical Cardiovascular Outcomes in Coronary Artery Disease Patients on Clopidogrel Treatment
  106. Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
  107. Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a)
  108. Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes
  109. Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
  110. Diffuse Arterial Thrombosis as a First Manifestation of Occult Malignancy
  111. Antiphospholipid Syndrome - A Case Report of Pulmonary Thromboembolism, Followed with Acute Myocardial Infarction in Patient with Systemic Sclerosis
  112. Effects of rosuvastatin versus atorvastatin alone or in combination, on lipoprotein (a): a single center study.
  113. Newly Diagnosed Diabetes and Stress Glycaemia and Its’ Association with Acute Coronary Syndrome
  114. Poster Session 3: Tuesday 5 May 2015, 08:30-12:30 * Room: Poster Area
  115. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey
  116. SEX-RELATED DIFFERENCES IN ACUTE CORONARY CARE AMONG PATIENTS WITH MYOCARDIAL INFARCTION: THE ROLE OF PRE-HOSPITAL DELAY
  117. Frequencies of Single-Nucleotide Polymorphisms and Haplotypes of the SLCO1B1 Gene in Selected Populations of the Western Balkans
  118. 2014 ESC/ESA Guidelines on non-cardiac surgery
  119. Bergamo, Marija
  120. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
  121. Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency
  122. Cardiovascular Disease
  123. Myocardial gated SPECT imaging in asymptomatic diabetic patients: clinical decision and optimal therapeutic approach
  124. Poster Session 1: Thursday 8 December 2011, 08:30-12:30 * Location: Poster Area
  125. Abstracts
  126. Occurrence and Progression of Coronary Artery Disease in Patients with Type 2 Diabetes
  127. ESTIMATION OF METABOLIC SYNDROME' COMPONENTS IN TYPE 2 DIABETIC POPULATION WITH CORONARY ARTERY DISEASE – A COMPARISON OF TWO CRITERIA
  128. Functional outcome and quality of life after coronary artery bypass surgery in patients with severe heart failure and hibernated myocardium
  129. ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
  130. 6.29Diagnostic value of transient ischaemic dilation (TID) and increased lung uptake as markers of severe and extensive myocardial ischaemia
  131. 1.18Combined low level treadmill-dipyridamol versus dipyridamol stress protocol in patients undergoing SPECT MPI
  132. 8.1Influence of hibernated myocardium on left ventricular remodelling in patients with severe ischaemic heart failure and coronary artery bypass surgery
  133. 6.20hs-CRP values in patients with normal myocardial perfusion
  134. Mo-P4:253 Relationship between extend of myocardial viability and post-revascularization improvement of left ventricular ejection fraction
  135. Prognosis and risk stratification of diabetic patients after coronary stenting: Impact of silent ischemia on cardiovascular events
  136. Is there a relationship between myocardial perfusion scintigraphy and carotid ultrasound findings in predictive model for coronary artery bypass patients?
  137. The influence of combined therapy with perindopril and trimetazidine on the silent myocardial ischemia and on left ventricular remodeling in essential hypertension
  138. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  139. 377 Impact of anemia and cachexia upon mortality in chronic heart failure
  140. M.521 Implication of body mass index on long-term prognosis in patients after coronary artery bypass surgery
  141. Compact reversal rotationally shearing interferometer
  142. 1864 Assessment of myocardial perfusion after coronary stenting and implications of incomplete revascularization in multivessel coronary disease: role of gated single-photon emission computed tomography imaging
  143. Left ventricular perfusion/function differences between ischemic and dilated cardiomyopathy assessed by SPECT myocardial imaging: visual and quantitative computer analysis
  144. 1.25 Dipyridamole myoscintigraphy in patients with left bundle branch block
  145. 7.58 Myocardial viability: nitrate enhanced gated SPECT MIBI Tc99m an adequate alternation for Tl201 rest-redistribution protocol
  146. 1.38 Significance of ST-segment changes detected by ambulatory electrocardiographic monitoring and exercise treadmill stress testing in female patients who underwent myocardial perfusion scintigraphy
  147. 16.10 Evaluation of diagnostic and prognostic markers of myocardial perfusion scintigraphy and exercise treadmill stress test in patients with multivessel coronary artery disease
  148. Myocardial perfusion scintigraphic findings in patients with ischaemic cardyomiopathy versus those with preserved left ventricular function
  149. Bisoprolol reduces episodes of ventricular tachycardia and sudden cardiac death in subjects with chronic heart failure